The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Open accessAbstract
Purpose We evaluated the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) variant pathogenicity guidelines for internal consistency and compatibility with Bayesian statistical reasoning.Methods The ACMG/AMP criteria were translated into a naive Bayesian classifier, assuming four levels of evidence and exponentially scaled odds of pathogenicity. We tested this framework with a range of prior probabilities and odds of pathogenicity.Results We modeled the ACMG/AMP guidelines using biologically plausible assumptions. Most ACMG/AMP combining criteria were compatible. One ACMG/AMP likely pathogenic combination was mathematically equivalent to pathogenic and one ACMG/AMP pathogenic combination was actually likely pathogenic. We modeled combinations that include evidence for and against pathogenicity, showing that our approach scored some combinations as pathogenic or likely pathogenic that ACMG/AMP would designate as variant of uncertain significance (VUS).Conclusion By transforming the ACMG/AMP guidelines into a Bayesian framework, we provide a mathematical foundation for what was a qualitative heuristic. Only 2 of the 18 existing ACMG/AMP evidence combinations were mathematically inconsistent with the overall framework. Mixed combinations of pathogenic and benign evidence could yield a likely pathogenic, likely benign, or VUS result. This quantitative framework validates the approach adopted by the ACMG/AMP, provides opportunities to further refine evidence categories and combining rules, and supports efforts to automate components of variant pathogenicity assessments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This procedure yielded a prior probability of pathogenicity (prevalence in the data set) of 4.41%, higher than that estimated previously for an exome of a healthy individual19 using a similar procedure but lower than the prevalence of 10% assumed by Tavtigian et al.9 for clinical sequencing data.”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Under reasonable assumptions, we used a positive likelihood ratio of pathogenicity to quantify the strength of evidence that corresponds to a supporting level of evidence and established that, within this framework, the strength of evidence required for moderate, strong, and very strong rose exponentially.9”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“We have previously modeled the ACMG/AMP rules for combining evidence and showed how they fit a probabilistic framework.9”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These fractions were smaller than the experience-based prior probability assumed by Tavtigian et al.9 (10%) and the prior probability that was estimated in this study using the gnomAD set (4.41%).”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as Tavtigian et al.9
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Self-citationInSiGHT, O. B. O., Thompson, B. A., Spurdle, A. B., Plazzer, J., Greenblatt, M. S., Akagi, K., Al‐Mulla, F., Bapat, B. V., Bernstein, I., Capellá, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2854 · Cited by 468
Self-citationEaston, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationGoldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, Á. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 388
Self-citationTavtigian, S. V., Byrnes, G. B., Goldgar, D. E., & Thomas, A. (2008) · Human Mutation · doi:10.1002/humu.20896 · Cited by 233
Self-citationAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variation
Abkevich, V., Zharkikh, A., Deffenbaugh, A. M., Frank, D., Chen, Y., Shattuck, D., Skolnick, M. H., Gutin, A., & Tavtigian, S. V. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015867 · Cited by 157
Self-citationA Full-Likelihood Method for the Evaluation of Causality of Sequence Variants from Family Data
Thompson, D. J., Easton, D. F., & Goldgar, D. E. (2003) · The American Journal of Human Genetics · doi:10.1086/378100 · Cited by 141
Thompson, B. A., Goldgar, D. E., Paterson, C. A., Clendenning, M., Walters, R., Arnold, S., Parsons, M. T., Walsh, M. D., Gallinger, S., Haile, R. W., et al. (2012) · Human Mutation · doi:10.1002/humu.22213 · Cited by 95
Self-citationThompson, B. A., Greenblatt, M. S., Vallee, M. P., Herkert, J. C., Tessereau, C., Young, E. L., Adzhubey, I. A., Li, B., Bell, R., Feng, B., et al. (2013) · Human Mutation · doi:10.1002/humu.22214 · Cited by 95
Self-citation
Cited by
Sorted by citations
Items 401–500 of 595
Cardona, D. S., Valencia-Arango, J. P., Gallo, J. P., Bustamante, C., Salazar, R., Carmona, C. A., Vanegas, M. S. N., Jaramillo, C. J., Moncada, J. E., Velasco, H. M., et al. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102940 · Cited by 1
Variation spectra in mild isolated hyperthyrotropinemia: pilot cohort and systematic review
Ricci, V., Masnata, M. E., Gonzalez, M. D. V., Enacán, R. E., Izquierdo, A., Adrover, E., Azcoiti, M. E., Sansó, G., Scaglia, P. A., Rivolta, C. M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1612450 · Cited by 1
Gupta, S., Srivastava, P., Daniel, R., Bhardwaj, C., Kaur, P., Bawa, P., Kumari, A., Bhadoriya, R. P. S., Peters, M., Kaur, A., et al. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1677143 · Cited by 1
Moghadasi, S., Zanti, M., Bleeker, F. E., Blok, M. J., Braspenning, M. E., Černá, M., Collee, M. J., Engel, C., Hopman, S. M. J., Kleiblová, P., et al. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2025-111145 · Cited by 1
Fernández‐Cadena, J. C., Naylor, E. W., Reinhard, H., & Bhattacharjee, A. (2026) · International Journal of Translational Medicine · doi:10.3390/ijtm6010005 · Cited by 1
Bahmane, K., Bhattacharya, S., & Kassem, M. A. (2026) · Journal of Genome Biotechnology and Genetics · doi:10.3390/jgbg1010003 · Cited by 1
Genetic analysis of neurodegenerative diseases
Grassano, M., Schindler, A. B., Traynor, B. J., & Scholz, S. W. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199840 · Cited by 1
Rosato, B. E., Marra, R., Martone, S., Manno, M., Dionisi, M., Ribersani, M., Pinto, V. M., Forni, G. L., Balocco, M., Carrara, P., et al. (2026) · Blood · doi:10.1182/blood.2025031632 · Cited by 2
Park, S. K., Lee, J., Park, S. J., Kim, Y. N., Shin, G. H., Han, D., Choi, H., Han, D., Hwang, B. J., & Choi, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2523210123 · Cited by 1
Ferreira, E. A., Oud, M. M., Kamsteeg, E., van Karnebeek, C., Langeveld, M., Leter, E. M., Vogel, M. J., Wolf, N. I., Roosendaal, S. D., van Dillen, J. J., et al. (2026) · Frontiers in Radiology · doi:10.3389/fradi.2026.1782924 · Cited by 1
Decoding variants of uncertain significance in systemic autoinflammatory diseases
Boursier, G., Carbone, A., Savic, S., & Henry, T. (2026) · Nature Reviews Rheumatology · doi:10.1038/s41584-026-01380-8 · Cited by 2
Schnaiter, S., Santer, F. R., Csanaky, K., Jensen, L. A., Zeimet, A. G., Michailidou, K., Spurdle, A. B., & Thomassen, M. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.05.015 · Cited by 1
Mitev, V. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1925492 · Cited by 1
Hsieh, T., Todd, D., Warner, T., Blankenship, K., Saade, D. N., Weiland, H., Bhasin, M. A., Klinkhammer, H., Li, J.-M., Krawitz, P. M., et al. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200384 · Cited by 1
Ye, S., Wang, L., & Chen, P. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1880490 · Cited by 1
Genetic testing in paediatric neurology – which test to choose?
Radford, E. J., Parker, A. P. J., & Firth, H. V. (2021) · Paediatrics and Child Health · doi:10.1016/j.paed.2021.02.004 · Cited by 1
Implications of BRCA1, BRCA2 Gene in Overall Development and Prognosis of Breast Cancer
Mansoor, S., Manzoor, U., Koul, A. M., Baba, S. M., Amin, I., Anwar, I., Aein, Q. U., & Pandith, A. A. (2022) · Springer eBooks · doi:10.1007/978-981-19-0197-3_5 · Cited by 1
Tibelius, A., Evers, C., Oeser, S., Rinke, I., Jauch, A. S., & Hinderhofer, K. (2023) · Genes · doi:10.3390/genes14122218 · Cited by 1
Rañola, J. M. O., Horton, C., Pesaran, T. F., Fayer, S., Starita, L. M., & Shirts, B. H. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05920-5 · Cited by 1
On exact Bayesian credible sets for discrete parameters
Song, C., & Li, B. (2024) · Statistics & Probability Letters · doi:10.1016/j.spl.2024.110295 · Cited by 1
Young, B., Neklason, D. W., Clark, K. A., Feng, B., Keener, M. B., Tuohy, T. M. F., Wood, A. C., McKinnon, W. C., Greenblatt, M. S., & Tavtigian, S. V. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63992 · Cited by 1
Self-citationLaner, A., Zilfalil, B. A., Hamed, S. A., Do, H., Lopes‐Cendes, Í., Shrestha, T., Tobias, E. S., Solano, A. R., Hamosh, A., & Kumar, D. (2025) · Annals of Human Genetics · doi:10.1111/ahg.70009 · Cited by 1
Pew, S., Wiffler, M. B., Thomas, A., Boyle, J. L., Cline, M., Camp, N. J., Goldgar, D. E., & Tavtigian, S. V. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.07.011 · Cited by 2
Self-citationThe Evolution of Constitutional Sequence Variant Interpretation
Mester, J. L., & Pesaran, T. F. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.02.005 · Cited by 1
Phenotype evaluation and clinical context
Garrett, A., & Turnbull, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00017-x · Cited by 1
Thompson, B. A., & Fortuño, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00001-6 · Cited by 2
Analysis of Novel Variants Associated with Three Human Ovarian Cancer Cell Lines
Mekala, V. R., Chang, J., & Ng, K. (2022) · Current Bioinformatics · doi:10.2174/1574893617666220224105106 · Cited by 1
Li, A., He, Q., Li, R., Chen, Y., & Xu, W. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/4696128 · Cited by 1
RetractedA Bayesian method using sparse data to estimate penetrance of disease-associated genetic variantsPreprint
Kroncke, B. M., Smith, D. K., Glazer, A. M., Roden, D. M., & Blume, J. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/571158 · Cited by 1
Young, C. C., Feng, B., Mackenzie, C. B., Girard, E., Hu, D., Iwasaki, Y., Momozawa, Y., Lesueur, F., Ziv, E., Neuhausen, S. L., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/835264 · Cited by 1
Self-citationBiesecker, L. G., Harrison, S. M., & Rehm, H. L. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-01032-6 · Cited by 1
Self-citationPandora will never regret having opened her box: reappraisal of genes associated with CPVT and SQTS
Horie, M., Ohno, S., & Ai, T. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab794 · Cited by 1
Geck, R. C., Powell, N. R., & Dunham, M. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.14.508023 · Cited by 1
Kim, H. H., Woo, J., Kim, D., Lee, J., Seo, G. H., Lee, H., & Lee, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511857 · Cited by 1
Cannon, S., Williams, M., Gunning, A. C., & Wright, C. F. (2022) · medRxiv · doi:10.1101/2022.10.27.22281598 · Cited by 1
Spurdle, A. B., Drackley, A., Ing, A. Y., Tudini, E., Yap, K. L., & Tavtigian, S. V. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100868 · Cited by 1
Self-citationThe qMini assay identifies an overlooked class of splice variantsPreprint
Guan, B., Bender, C., Pantrangi, M., Moore, N., Reeves, M. J., Naik, A., Li, H., Goetz, K., Blain, D., Agather, A. R., et al. (2023) · medRxiv · doi:10.1101/2023.11.02.23297963 · Cited by 1
A missense variant effect map for the human tumour suppressor protein CHK2Preprint
Gebbia, M., Zimmerman, D., Jiang, R., Nguyen, M., Weile, J., Li, R., Gavac, M., Kishore, N., Sun, S., Boonen, R. A. C. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.13.579700 · Cited by 1
Optimizing clinical interpretability of functional evidence in epilepsy-related ion channel variantsPreprint
Parthasarathy, S., Cohen, S. R., Fitch, E., Vaidiswaran, P., Ruggiero, S. M., Lusk, L. G., Chisari, V., Lewis‐Smith, D., Lauxmann, S., Boßelmann, C. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.09.593343 · Cited by 1
Cheng, H., Wang, X., Zhong, M., Geng, J., Li, W., Pei, K., Lu, Y., Cheng, J., Bu, F., & Yuan, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.19.608726 · Cited by 1
Moghadasi, S., Monajemi, R., Braspenning, M. E., Vreeswijk, M. P. G., & Rodríguez‐Girondo, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.23.614309 · Cited by 1
Lin, P., & Brandes, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678417 · Cited by 1
The ten year evolution of Sherloc, a points-based framework for genetic variant classificationPreprint
Kobayashi, Y., Westbrook, M. J., Tan, C. A., Márquez‐Luna, C., Wahl, A., Swartzlander, D. B., Ouyang, K., & Daber, R. D. (2025) · medRxiv · doi:10.1101/2025.11.24.25340888 · Cited by 1
Darrah, K. E., Hemker, S. L., Rawal, Y., Goff, N. J., Parker, P. S., Ganesan, G., Stratton, C. M., Oppenheimer, K., Roberts, E., Glick, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.11.698865 · Cited by 1
Yépez, V. A., Luknárová, R., Beijer, D., Estévez‐Arias, B., Mei, D., Morsy, H., Mueller, J. S., Polavarapu, K., Demidov, G. M., Doornbos, C., et al. (2026) · medRxiv · doi:10.64898/2026.02.10.26345954 · Cited by 4
Gene- and domain-aware calibration increases the clinical utility of variant effect predictorsPreprint
Chen, Y. P., Fayer, S., Jain, S., Benazouz, M., Sverchkov, Y., Stone, J., Sharma, H., Bergquist, T., Stewart, R., Mooney, S. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.17.706269 · Cited by 3
Using somatic data to aid germline clinical variant interpretation in developmental disordersPreprint
Andrews, K. A., Neville, M. D. C., Martincorena, I., Rahbari, R., Firth, H., Lindsay, S., Tischkowitz, M. D., & Hurles, M. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.17.732808 · Cited by 1
Wang, N. K., & Chiang, J. P. W. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0621-z
The Evolution of Constitutional Sequence Variant Interpretation
Mester, J. L., & Pesaran, T. F. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.06.001
Variant Interpretation and Genomic Medicine
Carss, K., Goldstein, D. B., Aggarwal, V. S., & Petrovski, S. (2019) · Wiley eBooks · doi:10.1002/9781119487845.ch27 · Cited by 1
Kalra, S., Jain, S., & Joshi, D. (2019) · Asian Journal of Pediatric Nephrology · doi:10.4103/ajpn.ajpn_11_19
Family-specific genetic variants: Principles, detection, and clinical interpretation
Shirts, B. H., Henrich, V. C., & Orlando, L. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816015-2.00004-3
Vargas‐Parra, G., Valle, J. D., Rofes, P., Gausachs, M., Stradella, A., Moreno-Cabrera, J. M., Velasco, À., Tornero, E., Menéndez, M., Muñoz, X., et al. (2020) · doi:10.22541/au.159050458.86704879
Functional Predictors of Causative Cis -Regulatory Mutations in Mendelian DiseasePreprint
Bengani, H., Grozeva, D., Moyon, L., Bhatia, S., Louros, S. R., Hope, J. E., Jackson, A., Prendergast, J. G. D., Owen, L. J., Naville, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.03.232926
Use of “Coldspot” Regions in Variant Classification
Harrison, S. M., & Funke, B. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa133
Self-citationShen, J. J., Wortmann, S. B., Kluijtmans, L. A. J., Collins, C. D., van der Lee, R., van Karnebeek, C., & Hegde, M. (2021) · Genetics in Medicine · doi:10.1038/s41436-020-01055-z
International consensus guidelines for constitutional sequence variant interpretation
Harrison, S. M., Pesaran, T. F., & Mester, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00005-3
Self-citationMcNulty, S. M., Cole, Y., Powell, B. C., & Rentas, S. (2021) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2021.07.001
Luo, X., Maciaszek, J. L., Thompson, B. A., Leong, H. S., Dixon, K., Sousa, S., Anderson, M., Roberts, M. E., Lee, K., Spurdle, A. B., et al. (2021) · medRxiv · doi:10.1101/2021.11.01.21265332
Sub-Pixel Depth Perception Based on Flexible and Separated Structured Light
Wang, H., Li, D., Xu, F., & Wang, Y. (2021) · IEEE International Conference on Cyber Technology in Automation, Control, and Intelligent Systems · doi:10.1109/cyber53097.2021.9588196
Influence of pressure on the yields from low-temperature distillation of coal
Ŝimek, B. G., Ludmila, J., & Edinger, J. E. (1949) · Paliva
Una visión crítica de Andalucía en el siglo XVIII
Alonso, M. M. (1982) · Revista de occidente
Genetic and Epigenetic Basis of Development and Disease
Kaub, P. A., & Barnett, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-84168-3_3
Krawitz, P. M., Brand, F., & Perne, C. (2022) · doi:10.22541/au.165034983.37804195/v1
Desregulación del splicing del gen PALB2 en cáncer de mama hereditario
Valenzuela‐Palomo, A. (2022) · doi:10.35376/10324/55378
Interpretation of Variants in Clinical Genomics
Jackson, M., & Stobo, D. (2023) · Wiley eBooks · doi:10.1002/9780470015902.a0029525
Villani, R. M., McKenzie, M. E., Davidson, A. L., & Spurdle, A. B. (2023) · medRxiv · doi:10.1101/2023.12.21.23300413
Zhao, X., Li, X., Yu, M., Jia, J.-A., Tian, R., & Zhu, F. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09092-y
Leveraging cancer mutation data to predict the pathogenicity of germline missense variantsPreprint
Haque, B., Cheerie, D., Pan, A., Curtis, M., Nalpathamkalam, T., Nguyen, J., Salhab, C., Thiruvahindrapura, B., Zhang, J., Couse, M., et al. (2024) · medRxiv · doi:10.1101/2024.03.11.24304106
Scott, A. J., Hernandez, F., Chamberlin, A. C., Smith, C., Karam, R., & Kitzman, J. O. (2023) · Figshare · doi:10.6084/m9.figshare.22598654
Quaio, C. R. D. C., Ceroni, J. R. M., Pereira, M. A., Teixeira, A. C. B., Yamada, R. Y., Cintra, V. P., Perrone, E., Silva, M. D. F. B., Chen, K., Minillo, R. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24571866
Scott, A. J., Hernandez, F., Chamberlin, A. C., Smith, C., Karam, R., & Kitzman, J. O. (2023) · Figshare · doi:10.6084/m9.figshare.22598651
Liu, S., Zhong, M., Huang, Y., Zhang, Q., Chen, T., Xu, X., Peng, W., Wang, X., Feng, X., Kang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24864106
Yin, X., Richardson, M. E., Laner, A., Shi, X., Ognedal, E., Vasta, V., Hansen, T. V. O., Pineda, M., Ritter, D., den Dunnen, J. T., et al. (2024) · medRxiv · doi:10.1101/2024.05.03.24306761
Self-citationOn Exact Bayesian Credible Sets for Classification and Pattern RecognitionPreprint
Song, C., & Li, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4821914
Xiao, D., Shi, C., Zhang, Y., Li, S., Ye, Y., Yuan, G., Miu, T., Ma, H., Diao, S.-G., Su, C., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1403913
A tandem duplication of exon 42 of the DMD gene is a likely benign variant
Hayesmoore, J. B. G., Newbury-Ecob, R. A., Durell, S., Dillon, A., Kanani, F., Beecroft, F., Jarvis, J., Cilliers, D. D., & Fratter, C. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110159
Hsieh, T., Todd, D., Warner, T., Blankenship, K., Saade, D., Weiland, H., Bhasin, M. A., Klinkhammer, H., Li, J.-M., Krawitz, P. M., et al. (2025) · medRxiv · doi:10.1101/2025.02.12.25321927
Predicting the Pathogenic Effects of Non-Synonymous Single Nucleotide Variants in Human Diseases
Nisamudheen, N. A., Balyan, P., Banu, A., Mohammed, F. K., Velayutham, D., Balyan, M. K., & Jithesh, P. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00291-8
Ying, E. Z., Douglass, A., Hawari, M. A., Groom, L. A., Stowell, K. M., Dirksen, R. T., Johnston, J. J., & Biesecker, L. G. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf038
Self-citationCardiac arrhythmias and genetics – current stage
Schulze-Bahr, Dittmann, S., & Kerkering, J. (2025) · Medizinische Genetik · doi:10.1515/medgen-2025-2006
Fortuño, C., Zhang, J., Koufariotis, L. T., Hollway, G. E., Wood, S., Pearson, J. V., Simpson, P. T., Lakhani, S. R., Reed, A. E. M., Thorne, H., et al. (2025) · medRxiv · doi:10.1101/2025.06.12.25329237
Implementing secondary findings analysis in a genetic and environmental research study
Johnston, J. J., Sapp, J. C., Yoo, S., Wermers, Z., Hernandez, S., Motsinger‐Reif, A. A., Burkholder, A., Fargo, D. C., Emerson, J. L., Hall, J. E., et al. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101515
Self-citationPrenatally and postnatally sequential genetic etiology detection in corpus callosum abnormalities
Xue, H., Yu, A., Zheng, L., Ye, X. Z., Zhang, L., Guo, Q., Chen, L., Shen, Q., lin, N., Huang, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07105-3 · Cited by 2
Comprehensively Testing the Function of Missense Variation in the STK11 Tumour SuppressorPreprint
Zimmerman, D., Coté, A. G., van Loggerenberg, W., Gebbia, M., Kishore, N., Weile, J., Li, R., Reno, C., Marsh, A. P. L., Hernandez, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.14.664734 · Cited by 1
Zhang, W., Duong, H., Jongkhajornpong, P., Hang, D. T. T., PHAM, H., Truc, M. N. T., Choo, C. H., Williams, D., Nguyen, X., Nguyen, T. D., et al. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.08.006
Peng, T., Chang, D., Chen, T., Chen, S., Wang, L., & Li, G. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2553384
Mishra, D., Tiwari, A., Srivastava, S., Tripathi, M., & Kapoor, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.23.678112
Case Report: Evaluation of COL4A5 non-canonical splicing variants in two families
Koh, C. T., Lim, T. S. T., Loh, A. H. L., Ng, Y. F., Kwek, J. L., Lau, P. Y. W., Chin, H.-L. L., Ng, J. L., Than, M., Mok, I. Y. J., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1611334
Refinement of the Classification of DDX41 Variants Through Analysis of Aggregated Clinical DatasetsPreprint
Tiong, I. S., Hunter, S. M., Kankanige, Y., Mehta, N. N., Chisholm, R. A., Wu, S., Li, J., Casan, J. M. L., Chan, K. L., Godley, L. A., et al. (2025) · medRxiv · doi:10.1101/2025.10.07.25335301
Müller, P., Lerche, H., & Boßelmann, C. M. (2025) · Epilepsia Open · doi:10.1002/epi4.70154
Evaluating ACMG/ClinGen PP3/BP4 recommendations for missense variants in CSNK2A1
Okur, V. (2025) · Pamukkale Medical Journal · doi:10.31362/patd.1784740
Llinares‐Burguet, I., Sanoguera‐Miralles, L., Bueno‐Martínez, E., García‐Álvarez, A., Valenzuela‐Palomo, A., Pérez‐Segura, P., de la Hoya, M., & Velasco, E. A. (2025) · The Journal of Pathology · doi:10.1002/path.6497
Villani, R. M., Terrill, B., Tudini, E., Matotek, E., Mattiske, T., Cliffe, C. C., Thompson, B. A., Satgunaseelan, L., Hahn, C. N., Lundie, B., et al. (2025) · medRxiv · doi:10.1101/2025.11.10.25339935
Systematic and proactive evaluation of AIRE missense variant effects
Axakova, A., Berger, A. H., van Loggerenberg, W., Kishore, N., Gebbia, M., Ding, M., Douville, S. V., Tabet, D. R., Coté, A. G., Weile, J., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.07.008 · Cited by 1
Experimental insights into MMACHC variants using a novel minigene system
Dong, Y., Xu, X., Li, W., Wang, L., Wu, B., Wang, P., Li, D., Shu, J., & Cai, C. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109292
Labory, J., Boulaimen, Y., Singh, J., Ait-El-Mkadem, S., Paquis‐Flucklinger, V., Bannwarth, S., & Bottini, S. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf612
Ramachandran, I., Anugonda, N., & Rajamani, A. (2025) · IEEE India Council International Subsections Conference (INDISCON) · doi:10.1109/indiscon66021.2025.11253793
Bora, N., Badonyi, M., Pathak, A. K., Manisekaran, R. G., Marsh, J. A., & Ngeow, J. Y. Y. (2025) · medRxiv · doi:10.64898/2025.12.08.25341119
Metadata
- Authors
- Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L., Prabhu, S. A., Boucher, K. M., & Biesecker, L. G.
- Affiliations
- University of Utah (US)
- University of Vermont (US)
- Harvard University (US)
- Invitae (United States) (US)
- Stanford University (US)
- National Institutes of Health (US)
- Corresponding author
- Tavtigian, Sean V.
- ORCID
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 20
- Issue
- 9
- Pages
- 1054-1060
- ISSN
- 1098-3600 (ISSN-L)
- PMC
- PMC6336098
- OpenAlex
- W2781534540
- Cited by
- 590
- References
- 10
- Citations by year
- 2026: 113 · 2025: 81 · 2024: 77 · 2023: 72 · 2022: 84 · 2021: 57 · 2020: 48 · 2019: 37 · 2018: 18
- FWCI
- 24.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Connecticut
- Johns Hopkins University
- Wellcome Trust
- Huntsman Cancer Institute (P30CA042014)
- Invitae
- University of Cambridge
- National Institutes of Health
- University of North Carolina at Chapel Hill
- School of Medicine
- National Human Genome Research Institute (HG200388 03, U41HG009650, U41HG006834, U01HG007436, HG200387, HG200388, U01HG007437, U41HG009649, ZIAHG200388, U24HG009650, ZIAHG200387)
- National Cancer Institute (R01CA164944, R01CA121245, P30CA042014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- variant pathogenicity assessment, Bayesian classification, naive Bayesian classifier, variants of uncertain significance, combining rules, prior probability
- MeSH terms
- Bayes Theorem, Genetic Testing, Humans, Software, Genetic Variation, Genome, Human, Sequence Analysis, DNA, Computational Biology, Genomics, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review